Physician profile
I-Hui Chiang
NPI 1407065220
$27,368.46
in general payments reported to CMS, 2019-2025
21 companies · $4,671 in 2025
The $4,671 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50.00 · 2020: $137 · 2021: $1,738 · 2022: $5,978 · 2023: $4,363 · 2024: $10K · 2025: $4,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,723 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,773 · Travel and Lodging: $3,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,723.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,772.50 |
| Travel and Lodging | $3,969.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $7,514.39 | 2022-2024 | Lifesparc |
| Abiomed | $4,913.59 | 2021-2025 | Impella |
| Shockwave Medical, INC | $3,398.23 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $2,708.07 | 2020-2025 | Optis, Ensite, Dragonfly Opstar |
| Penumbra, INC. | $2,499.41 | 2022 | |
| Medtronic, INC. | $1,223.66 | 2024-2025 | Symplicity G3, Resolute Onyx |
| Medical Device Business Services, INC. | $1,215.77 | 2023 | Carto 3 |
| Biosense Webster, INC. | $1,049.43 | 2023-2025 | Carto 3 |
| W. L. Gore & Associates, INC. | $977.70 | 2022-2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder |
| Boston Scientific Corporation | $687.16 | 2020-2025 | Avvigo Guidance System, Comet |
| Edwards Lifesciences Corporation | $309.66 | 2023-2025 | Sapien 3 Ultra Resilia, Pascal |
| Atricure, INC. | $183.43 | 2024 | |
| Inari Medical, INC. | $172.00 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Bardy Diagnostics, INC. | $145.00 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.62 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $102.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $61.69 | 2022-2024 | |
| Cordis US Corp. | $33.12 | 2025 | Mynx Control Venous |
| Amgen INC. | $20.74 | 2024 | Repatha |
| Janssen Pharmaceuticals, INC | $12.89 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw I-Hui Chiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.